Streetbeat News

Analyst Ratings

AAPL

AMD

AMZN

ASHR

BTCUSD

GOOG

META

MSFT

NVDA

SSNLF

TSLA

TSM

China's producer deflation and its potential impact on the global economy, including the U.S., is highlighted. The Chinese market has not seen a significant rally this year, unlike the U.S. market, which has been driven by an AI frenzy. The seven major stocks benefiting from this are Apple, Amazon, Alphabet, Meta Platforms, Microsoft, NVIDIA, and Tesla. China's CPI came at 0.0% year-over-year vs. 0.2% consensus, and PPI at -5.4% year-over-year vs. -5% consensus. The Chinese government is expected to provide stimulus to counter deflation, but investors are warned not to be overly optimistic due to China's local government debt issues. Negative data from Taiwan Semiconductor Manufacturing and Samsung Electronics, leading semiconductor manufacturers, is also noted.

Portfolio Pulse from The Arora Report

July 10, 2023 | 3:29 pm

CVNA

Carvana Co (NYSE:CVNA) shares have been trading higher, with gains of over 575% since the start of the year and 250% in the last three months. The surge was sparked by better-than-expected financial results and positive EBITDA expectations for Q2. The company also reported a lower quarterly loss than estimated due to a renewed focus on profitability. Carvana raised its Q2 outlook in June, leading to several analysts raising price targets. The company's total EV sales have increased by 786% over the past five years.

Portfolio Pulse from Adam Eckert

July 10, 2023 | 3:27 pm

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo discusses the trade strategy for SPY, QQQ, META, TSLA, MSFT, NVDA, and GOOGL. The memo provides key price levels for each stock, which are determined by a proprietary formula that takes into account price, volume, and options flow. The memo suggests that traders should closely monitor these stocks and be prepared to leverage potential breakouts or reversals.

Portfolio Pulse from RIPS

July 10, 2023 | 3:25 pm

PRTK

HC Wainwright & Co. analyst Ed Arce has reiterated a Neutral rating on Paratek Pharmaceuticals (NASDAQ:PRTK) and maintained a price target of $2.15.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 3:22 pm

IOVA

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on Iovance Biotherapeutics (NASDAQ:IOVA) and maintained a price target of $38.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 3:21 pm

PBLA

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a 'Buy' rating on Panbela Therapeutics (NASDAQ:PBLA) and maintained a $16 price target.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 3:20 pm

ATAI

HC Wainwright & Co. analyst Patrick Trucchio has reiterated a 'Buy' rating on ATAI Life Sciences (NASDAQ:ATAI) and maintained a $20 price target.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 3:18 pm

BWMX

Small Cap Consumer Research analyst Eric Beder has reiterated a 'Buy' rating on Betterware de Mexico SAPI (NASDAQ:BWMX) and raised the price target from $15 to $17.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 3:17 pm

FMC

Fermium Research analyst Frank Mitsch has maintained a 'Hold' rating on FMC (NYSE:FMC) and lowered the price target from $125 to $105.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 3:14 pm

FTNT

Fortinet shares are trading higher after Morgan Stanley maintained an Overweight rating on the stock and raised its price target from $77 to $84.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 3:12 pm